










































From man to mice - from mice to man
Citation for published version:
Lengeling, A 2002, 'From man to mice - from mice to man' Gene Function & Disease, vol 3, no. 3-4, pp. 67-
68.
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Preprint (usually an early version)
Published In:
Gene Function & Disease
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 20. Feb. 2015
Gene Funct. Dis. 2002, Vol. 3, 3-4, 6768 67
Guest Editorial
From man to mice  from mice to man
We have reached a new landmark in mouse genetics,
functional genome annotation and comparative gen-
omics. The sequence and analysis of more than 95%
of the mouse genome has been published for the first
time in Nature (Vol. 420, 5th December 2002). The
biomedical research community has now this superb
and freely available tool at their fingertips to tackle the
complexities of human disease by using the mouse
as a model.
After the publication of the human genome draft se-
quence a year ago, progress in sequencing has
meanwhile covered approximately 98% of the human
genome with about 95% in finished form. This re-
source has now been used for comparisons with the
mouse draft sequence. The results provide new im-
portant insights into structure and contents of both
genomes, with some unexpected surprises. The most
important findings are:
 Approximately 99% of all mouse genes have de-
tectable homologues in the human genome.
 The human and mouse gene catalogue contains
about 30,000 protein-coding genes, supporting the
earlier gene number estimates made from the hu-
man draft sequence. But the mouse genome is
14 % smaller than the human genome (2.5 Gb
compared with 2.9 Gb).
 About 1,200 new genes have been detected in the
human genome by comparisons of mouse and hu-
man sequences. Approximately 9,000 genes have
been found in the mouse for the first time.
 The analysis of the mouse transcriptome by the
FANTOM consortium of the RIKEN Institute has
revealed an unexpectedly large number of non-co-
ding RNAs, indicating that non-coding RNA is the
major component of the transcriptome.
 Some gene families have experienced a massive
expansion in the mouse lineage since the diver-
gence of rodents and humans. Mice have more
genes in gene families involved in olfaction, repro-
duction, immunity and host defence, reflecting dif-
ferent selection forces for these biological func-
tions in the two species.
 By comparing the draft sequence of the inbred
strain C57BL/6J with sequences generated from
 WILEY-VCH Verlag GmbH, 69451 Weinheim, 2002 0173-0835/02/0601-0067 $17.50+.50/0
other inbred mouse strains, about 80.000 single
nucleotide polymorphisms (SNPs) have been
identified. These SNPs are not evenly distributed
over the genome. They occur in large blocks, indi-
cating that the founder populations of laboratory
mouse strains were extremely limited. The con-
clusion is that the genetic variation among inbred
strains is much smaller than expected.
How will this sequencing endeavour change our daily
work? What impact will the mouse genome sequence
have on the elucidation of vertebrate gene functions?
Impact on gene targeting experiments
The key to understanding the function of a gene is
mutagenesis. By using knockout approaches through
homologous recombination in embryonic stem (ES)
cells, thousands of medically important loss-of-func-
tion mutations in mice have been generated. One of
the most time-consuming steps in the knockout busi-
ness is still the design and cloning of the targeting
construct. With the mouse sequence available, tedi-
ous restriction site mapping can be avoided. Tar-
geting vectors can be designed from the locus se-
quence in silico. Thus, the process of generating
transgenic mice will be sped-up tremendously. More-
over, sequence annotated C57BL/6J-BAC clones can
be directly ordered at genome resource centers and
used as DNA cloning resources for targeting con-
structs. In combination with C57BL/6J-ES cell lines
knockout and knockin alleles can be engineered from
the beginning in a homogeneous inbred background
and will render further extensive backcrosses dis-
pensable.
Impact on large-scale mutagenesis projects
Phenotype-driven large-scale mutagenesis projects
have opened a new avenue in the systematic pro-
duction of new mouse mutants. At least ten big
mouse mutagenesis centers have embarked on ran-
dom chemical mutagenesis by using ethylnitrosourea
(ENU) as an effective mutagen. Hundreds of novel
mouse mutant lines have been recovered by world-
wide mutagenesis screens. All these mutants are now
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waiting for the positional cloning of the underlying mo-
lecular gene lesion. With the complete mouse se-
quence at hand, every gene in a critical mapping in-
terval will be known, allowing a very effective candi-
date gene approach to find the mutation.
The same is true for several large-scale gene-trap
programmes that are underway to add more mutants
to the worldwide collection of mutant lines. The avail-
ability of the genome sequence will facilitate the de-
termination of the precise integration site of the “gene
trap reporter construct”. This allows a better selection
of targeted ES cells that can be subsequently used to
generate interesting mutants.
Revolutionizing the analysis of quantitative traits
One of the exciting brake-throughs can be expected
for the genetic characterization of multigenic and
quantitative traits in mice. Most of the medically im-
portant human diseases like diabetes, hypertension,
autoimmunity disorders, susceptibility to cancer and
infectious diseases are believed to be determined by
complex interactions of multiple genes. Many of these
complex traits can also be observed in crosses be-
tween inbred strains of mice that serve as animal mo-
dels for such disorders. The analysis of SNP distri-
butions among inbred strains has now shown that two
thirds of the mouse genome have a very low polymor-
phism rate, due to ancestral haplotypes which have
been inherited since the divergence of mouse sub-
strains. This means that positional cloning initiatives
of quantitative trait loci (QTLs) should focus on chro-
mosomal subregions of high SNP rates between par-
ental strains. More than 95% of the total genetic
variation will be found in these regions. By making
use of linkage disequilibrium between a phenotype
and particular ancestral haplotypes, it might be pos-
sible to identify a critical region where the causative
gene should be located. If QTLs have been mapped
in several strain combinations, a comparison of
haplotype distributions among the strains should al-
low to narrow the critical region to an even smaller
chromosomal interval.
Tasks for the future
To use the full potential of mouse inbred strains in the
genetic dissection of important traits, SNP data have
to be generated systematically in all commonly used
strains. This is a requirement to explore the fine struc-
ture of ancestral haplotypes at a resolution high
enough for QTL cloning. In addition, the valuable
resource of inbred strains needs to be systematically
phenotyped for as many physiologically and medi-
cally relevant parameters as possible. The recently
started Mouse Phenome project at the Jackson
Laboratory is an important new tool to make those
kinds of data freely available to the scientific com-
munity.
Not every human phenotype or disorder can be ex-
actly replicated in mouse models. The elucidation of
both genome sequences will further an improved
understanding of observed differences between mice
and man. But all comparative studies will depend on
the to-and-fro between the two genomes, the guiding
principle will be maintained - from man to mice and
back again from mice to man.
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